Cardiorenal syndrome describes the clinical consequences of the bidirectional influence that cardiac and renal dysfunction exert on each other—a domain in which single-organ care proves insufficient. A 2024 meta-analysis estimated the pooled prevalence of chronic kidney disease among patients with heart failure at 49%....
G. Gembillo, V. Calabrese, L. Soraci et al.· Medicina· 0 citations
In many immune-mediated kidney diseases, tissue injury is driven by dysregulated B-cell immunity, with autoantibodies and complement acting as key effectors at the glomerulus. Corticosteroids and conventional immunosuppressants control these diseases only in part, and they do so at the price of cumulative toxicity and...
L. Visconti, L. Soraci, Lorenzo Lo Cicero et al.· Future Pharmacology· 0 citations
Because a model can outperform clinicians in aggregate yet fail where oversight is least likely to detect it, evaluation of clinical AI should weigh error structure alongside accuracy.
R. Bellocco, L. Soraci, Lorenzo Lo Cicero et al.· Epidemiology Biostatistics a...· 0 citations
New therapies, including dual AT1/endothelin-A antagonism and podocyte-targeted approaches (apecotrep), show promising proteinuria reductions but have not yet demonstrated clear benefits on hard renal outcomes, while biomarker-driven strategies may enable more tailored treatment, although their clinical impact remains...
G. Gembillo, Chiara Casuscelli, A. La Spada et al.· Expert Opinion on Pharmacoth...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.